Improving Artificial Intelligence-derived Algorithms for Estimating Length and Weight in NEonateS… (NCT07514182) | Clinical Trial Compass
RecruitingNot Applicable
Improving Artificial Intelligence-derived Algorithms for Estimating Length and Weight in NEonateS and infanTs up to 6 Months of Age (NEST)
Singapore60 participantsStarted 2026-03-26
Plain-language summary
The NEST study is a prospective, observational research study designed to collect clinical measurements and image data to develop and evaluate artificial intelligence (AI)-derived algorithms for estimating anthropometric parameters in neonates and young infants. The study focuses on infants from birth up to 6 months of age and aims to assess the accuracy of AI-based estimations of length, weight, and head circumference using photographs and/or video recordings captured during routine clinical care. These AI-derived measurements will be compared against standard clinical measurements obtained by trained healthcare professionals in neonatal and infant care settings.
Who can participate
Age range
0 Days – 6 Months
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Infants up from birth up to 6 months of postnatal age (including neonates) who have been admitted to the NICU or SCN at the time of screening
. Parent(s) should be able to comprehend the content of the study and be willing for their child to undergo video and photo recording, and to allow access to their blood sampling results (haemoglobin) taken as part of standard clinical practice
. Written consent from parents and/or legally acceptable representative
Exclusion criteria
. Infants who were born with gestational age of less than 28 weeks of gestational age
. Infants who are intubated (i.e., endotracheal, nasotracheal intubation) at the time of screening
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
To evaluate the accuracy of the algorithm to estimate length (in cm)
Timeframe: From enrolment (after informed consent) until discharge from NICU/SCN, up to a maximum of 10 weeks
Trial details
NCT IDNCT07514182
SponsorDanone Asia Pacific Holdings Pte, Ltd.
Sponsor typeINDUSTRY
Study typeOBSERVATIONAL
Primary completion2026-10
Contact for this trial
Amilia Sng, Senior Digital Health R&I Study Manager, MSc Pharmacology
. The investigator considers for any reason that the participant would not be suitable for the study
. The participant has an existing medical condition that would prevent standardised measurement of length and/or head circumference e.g. structural abnormality of the lower limbs, orthopaedic conditions, hydrocephalus
. Employees and/or children/family members or relatives of employees of Danone Global Research \& Innovation Center, Danone Asia Pacific Holdings Pte Ltd, or the participating site